Chubb Limited (CB)
(Delayed Data from NYSE)
$293.10 USD
+5.70 (1.98%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $293.18 +0.08 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$293.10 USD
+5.70 (1.98%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $293.18 +0.08 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Zacks News
Here's Why You Should Buy Cincinnati Financial (CINF) Stock
by Zacks Equity Research
Cincinnati Financial's (CINF) higher level of insured exposures, rate increase, agent-focused business model, consistent cash flow and a solid capital position poise it well for growth.
SentinelOne (S) Rides on Expanding Clientele, Federal Footprint
by Zacks Equity Research
SentinelOne (S) is improving its footprint among federal agencies through the availability of the FedRAMP-authorized Singularity DataLake solution.
Why Chubb (CB) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why You Should Add Chubb (CB) Stock to Portfolio Now
by Zacks Equity Research
Chubb (CB) is poised to grow on a strong global presence, rate increases, improving underwriting margins, new business and strong renewal retention.
SentinelOne (S) Benefits from Robust Portfolio, Partner Base Strength
by Zacks Equity Research
SentinelOne (S) benefits from a robust portfolio and an expanding partner base.
Hanover Insurance's (THG) Segmental Strength Aids, Cat Loss Ails
by Zacks Equity Research
Hanover Insurance (THG) stands to gain from growth in the Core Commercial and Specialty segments, stable retention, better pricing, strong market presence and solid capital position.
Argo Group (ARGO) Banks on Segmental Growth Amid Cost Woes
by Zacks Equity Research
Argo Group (ARGO) stands to gain from highly profitable business, growth efforts, expense initiative program, investment in technology and a solid capital position.
Here's Why You Should Stay Invested in Nasdaq (NDAQ) Stock Now
by Zacks Equity Research
Improving organic growth, focus on ramping up the on-trading revenue base, buyouts to capitalize on growing market opportunities and effective capital deployment poise Nasdaq (NDAQ) for growth.
Should You Retain Willis Towers (WTW) in Your Portfolio?
by Zacks Equity Research
Willis Towers (WTW) stands to gain from growth across the global lines of business, strategic inorganic expansion, higher demand for products and advisory work and a solid balance sheet.
Chubb (CB), SentineIOne Unite to Enhance Cyber Insurance Offerings
by Zacks Equity Research
Chubb (CB) collaborates with SentineIOne to streamline its underwriting process for Cyber insurance.
Why Should You Stay Invested in Intercontinental (ICE) Stock?
by Zacks Equity Research
A compelling portfolio, expansive risk-management services, strategic buyouts, solid balance sheet and effective capital deployment poise Intercontinental (ICE) for growth.
CME Group (CME) Rises 19% YTD: Can It Retain the Bull Run?
by Zacks Equity Research
CME Group's (CME) global presence, compelling product portfolio and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
Should You Retain American Financial (AFG) in Your Portfolio?
by Zacks Equity Research
American Financial (AFG) stands to gain from business opportunities, growth in the surplus lines and excess liability businesses, higher average renewal pricing and effective capital deployment.
Should You Buy Reinsurance Group (RGA) for Better Returns Now?
by Zacks Equity Research
Reinsurance Group (RGA) is poised to grow from higher transaction and other fees, favorable estimates, stronger invested asset base, improved risk-free rates earned on new investments and prudent capital deployment.
Fidelity National (FNF) Rises 20% in 6 Months: More Room to Grow?
by Zacks Equity Research
Fidelity National's (FNF) market-leading position Higher direct premiums, agency premiums, strong origination demand and effective capital poise it well for growth.
Selective Insurance (SIGI) Rises 18.9% YTD: More Room to Run?
by Zacks Equity Research
Selective Insurance (SIGI) stock rallies on the back of exposure growth, solid retention rates, strong new business growth and higher income earned on fixed-income securities portfolio.
Zacks Industry Outlook Highlights Chubb, Arch Capital Group, Cincinnati Financial, Axis Capital Holdings and ProAssurance
by Zacks Equity Research
Chubb, Arch Capital Group, Cincinnati Financial, Axis Capital Holdings and ProAssurance are part of the Zacks Industry Outlook article.
5 Property & Casualty Insurers to Buy With Improving Pricing
by Tanuka De
Frequent catastrophes resulting in an accelerated policy renewal rate and upward pricing pressure are likely to boost the performance of Zacks Property and Casualty Insurance industry players like CB, ACGL, CINF, AXS and PRA.
AIG's Corebridge (CRBG) to Sell UK Life, Streamlines Operations
by Zacks Equity Research
Corebridge (CRBG) intensifies its focus on core business with the sale of UK Life business to Aviva plc.
CNO Financial (CNO) Gains 26% in a Year: More Room to Run?
by Zacks Equity Research
CNO Financial (CNO) is well-poised for growth on a diversified product portfolio, product launches and the prudent deployment of capital.
CB or TKOMY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CB vs. TKOMY: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva
by Zacks Equity Research
Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva are included in this Analyst Blog.
Top Stock Reports for Visa, Chubb & HCA Healthcare
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Chubb Limited (CB) and HCA Healthcare, Inc. (HCA).
Virtu Financial (VIRT) & SMTAM Unite to Improve Trading Workflow
by Zacks Equity Research
Virtu Financial (VIRT) collaborates with Sumitomo Mitsui Trust Asset Management to integrate its investment suite to improve workflows.
4 P&C Insurers to Add to Portfolio Amid a Sluggish September
by Tanuka De
Better pricing, increase in interest rate, exposure growth and solid capital position should help Axis Capital (AXS), Chubb Limited (CB), Cincinnati Financial (CINF) and First American Financial (FAF) deliver operational excellence and in turn better returns for investors.